State Trading Corporation of India Ltd
STCINDIAState Trading Corporation of India Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.
The sharpest disagreement: the price moved −3.2% in a year while annual EPS moved −51.6% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is building a base (7 weeks in) while the P/E sits at the 50th percentile of its own 5-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
State Trading Corporation of India Ltd trades at ₹121, building a base and 7 weeks into that stage. That is −1.2% against its own 200-day average. It sits at 46% of a 52-week range of ₹99 to ₹145. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).
Today the stock is building a base — week 7 of stage 1, confirmed. At ₹121 it trades −1.2% versus its 200-day average and sits at 46% of its 52-week range (₹99–₹145).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +39% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
State Trading Corporation of India Ltd trades at 16.2× P/E, mid-range by its own standards (50th percentile). Its long-run median P/E is 16.4×, measured across 4.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 16.2× is mid-range by its own standards (50th percentile), against a long-run median of 16.4× measured over 4.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −51.6% against a −3.2% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the +10.8%/yr price move, ~+11.8%/yr came from earnings growth and ~−1.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
State Trading Corporation of India Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 8 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Profit | −51.0% | — | — | — |
| EPS | −51.6% | — | — | — |
| Share price | −3.2% | +10.8% | +0.1% | +0.9% |
4-Factor Sector Score
44.8/100 — rank 24 of 48 in Trading · 54% evidence confidence
State Trading Corporation of India Ltd scores 44.8 out of 100 against the 48 companies it is compared with in Trading, ranking 24. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 18.6 + 7.5 + 12.1 + 6.6 = 44.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
State Trading Corporation of India Ltd reported ₹0.0 Cr of revenue in the Dec 25 quarter. The last full year, FY25, came in at ₹0.0 Cr. The last four reported quarters add to ₹0.0 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY25 revenue came in at ₹0.0 Cr (null on the year). The latest quarter (Dec 25) printed ₹0.0 Cr, null year on year.
Acceleration check: TTM profit +1,683.3% vs +282.0%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
A clean operating margin is not in our numbers for State Trading Corporation of India Ltd — its accounts do not report the operating-profit line this section reads, which is common for lenders and holding companies. The sections above and below carry the readings this company's filings do support.
This company's accounts do not report the operating-profit line this section reads — common for lenders and holding companies classified outside the financial bucket. The revenue and net-profit sections are the cleaner reads for State Trading Corporation of India Ltd.
🚨 Why the margin moved: operating margin went −111.5 pp year on year while gross margin went +98.9 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
State Trading Corporation of India Ltd earned ₹17.0 Cr of net profit in the Dec 25 quarter, +750.0% year on year. Full-year FY25 profit was ₹25.0 Cr. The same quarter a year earlier earned ₹2.0 Cr. 1 of the last 12 reported quarters were loss-making.
Dec 25 profit was ₹17.0 Cr, +750.0% year on year. On the full year, FY25 printed ₹25.0 Cr (−51.0%).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years −238% of State Trading Corporation of India Ltd's reported profit arrived as operating cash — a gap worth watching. In FY25 that was ₹−171 Cr of operating cash against ₹25.0 Cr of profit. After ₹0.0 Cr of capital spending, ₹−171 Cr was left as free cash.
FY25: operating cash of ₹−171 Cr against reported profit of ₹25.0 Cr, leaving free cash of ₹−171 Cr after ₹0.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is −238% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at −238%: the cash cycle tightened 5,65,853 days between FY17 and FY23 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
State Trading Corporation of India Ltd's cash conversion cycle runs −5,65,761 days in FY23, down from 92 days in FY17. Capital spending ran ₹0.0 Cr over the last 3 years. Customers take −5,65,729 days to pay and stock waits −32 days to sell.
FY23: debtors at −5,65,729 days, inventory at −32 days — roughly −1.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −5,65,761 days, tighter than FY17's 92.
On the investment side: capital spending of ₹0.0 Cr over the last 3 fiscal years. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
State Trading Corporation of India Ltd earns a ROCE of 87% in FY17. That is up from a trough of 23% in FY16. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −3,200.0% net margin on 0.00× asset turns.
FY17 ROCE is 87%, recovered from a FY16 trough of 23% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY23): −3,200.0% net margin × 0.00× asset turns × −0.50× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
State Trading Corporation of India Ltd's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from −0.43 in FY21 to −0.43 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Dec 25: total debt of ₹1,177 Cr against shareholder equity of ₹−3,981 Cr — a debt-to-equity of −0.30. On the annual view, debt-to-equity went from −0.43 (FY21) to −0.43 (FY25). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of State Trading Corporation of India Ltd moved a full percentage point over the last two years — the register is quiet. Promoters moved +0.0 points over the same window, to 90.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −0.1 points over 8 quarters to 0.5%; Promoters: +0.0 points over 8 quarters to 90.0%; Foreign institutions: +0.0 points over 8 quarters to 0.0%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
State Trading Corporation of India Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Rashi Peripherals LtdRPTECH | 67.0/100Favorable setup71% evidence | LEADER | 21.1/35 Revenue 14.9% · PAT 34.8% · OPM change -0.1 pp 83% evidence | 15.3/25 ROCE 16.8% · OPM 3% 76% evidence | 10.8/20 P/E 19.8× · PEG — 15% evidence | 19.8/20 RS sector 68.7% · RS bench 92.3% · 1Y 182.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 15.3 + 10.8 + 19.8 = 67 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Magnus Steel & Infra Ltd517320 | 66.9/100Thin evidence · provisional56% evidence | 27.1/35 Revenue 100% · PAT 100% · OPM change 1.6 pp 83% evidence | 18.6/25 ROCE 171% · OPM 21.3% 76% evidence | 9.2/20 P/E 92.5× · PEG — 15% evidence | 12.0/20 RS sector — · RS bench 46.1% · 1Y 1449.6%6 of 7 weeks ahead to 2026-06-28 25% evidence | |
| Exact sum: 27.1 + 18.6 + 9.2 + 12 = 66.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Shankara Buildpro LtdBUILDPRO | 63.2/100Thin evidence · provisional59% evidence | TURNING | 25.3/35 Revenue 28.8% · PAT 68.4% · OPM change 0.5 pp 88% evidence | 17.3/25 ROCE 39% · OPM 3.5% 100% evidence | 10.6/20 P/E 23.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence |
| Exact sum: 25.3 + 17.3 + 10.6 + 10 = 63.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Mangalam Global Enterprise LtdMGEL | 63.0/100Mixed-positive evidence65% evidence | TURNING | 24.4/35 Revenue 41.4% · PAT 100% · OPM change 0.5 pp 95% evidence | 16.6/25 ROCE 17% · OPM 1.9% 95% evidence | 11.1/20 P/E 14.2× · PEG — 15% evidence | 10.9/20 RS sector — · RS bench 10.1% · 1Y —3 of 3 weeks ahead 25% evidence |
| Exact sum: 24.4 + 16.6 + 11.1 + 10.9 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Vision Infra Equipment Solutions LtdVIESL | 60.7/100Thin evidence · provisional51% evidence | LEADER | 18.8/35 Revenue — · PAT — · OPM change 2 pp 13% evidence | 19.0/25 ROCE 19.6% · OPM 27% 95% evidence | 10.5/20 P/E 25.1× · PEG — 15% evidence | 12.4/20 RS sector 4.4% · RS bench 20.9% · 1Y 93.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 19 + 10.5 + 12.4 = 60.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Euro Pratik Sales LtdEUROPRATIK | 60.5/100Mixed-positive evidence69% evidence | TURNING | 14.5/35 Revenue 18% · PAT 4% · OPM change 1 pp 88% evidence | 21.1/25 ROCE 38.4% · OPM 27% 100% evidence | 14.9/20 P/E 37.6× · PEG 0.62 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y —7 of 10 weeks ahead 0% evidence |
| Exact sum: 14.5 + 21.1 + 14.9 + 10 = 60.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 7Sudarshan Pharma Industries Ltd543828 | 59.8/100Mixed-positive evidence78% evidence | LEADER | 18.5/35 Revenue 38.9% · PAT 53.3% · OPM change -1 pp 83% evidence | 14.3/25 ROCE 15.1% · OPM 9% 76% evidence | 9.1/20 P/E 39.1× · PEG — 50% evidence | 17.9/20 RS sector 9% · RS bench 27.5% · 1Y 45.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 14.3 + 9.1 + 17.9 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Lloyds Enterprises LtdLLOYDSENT | 55.6/100Mixed-positive evidence71% evidence | LEADER | 21.4/35 Revenue 18.2% · PAT 100% · OPM change 1 pp 83% evidence | 9.8/25 ROCE 3.7% · OPM 6% 76% evidence | 8.7/20 P/E 1106× · PEG — 15% evidence | 15.7/20 RS sector 4% · RS bench 22.5% · 1Y 10.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 21.4 + 9.8 + 8.7 + 15.7 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tembo Global Industries LtdTEMBO | 55.3/100Mixed-positive evidence70% evidence | ASLEEP | 20.0/35 Revenue 48.5% · PAT 78.2% · OPM change 1 pp 83% evidence | 18.0/25 ROCE 22.8% · OPM 11% 95% evidence | 11.3/20 P/E 11.2× · PEG — 15% evidence | 6.0/20 RS sector -24.8% · RS bench -8.2% · 1Y 10.6%5 of 10 weeks ahead 70% evidence |
| Exact sum: 20 + 18 + 11.3 + 6 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Yogi Ltd511702 | 54.5/100Mixed-positive evidence61% evidence | BREAKING OUT | 24.2/35 Revenue 100% · PAT 100% · OPM change 3.6 pp 53% evidence | 11.3/25 ROCE 12.8% · OPM 4.4% 76% evidence | 10.0/20 P/E 36.4× · PEG — 15% evidence | 9.0/20 RS sector -17.5% · RS bench -2.5% · 1Y -13.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 11.3 + 10 + 9 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Nupur Recyclers LtdNRL | 53.8/100Mixed-positive evidence68% evidence | TURNING | 15.9/35 Revenue 36.4% · PAT 1.2% · OPM change 1.1 pp 83% evidence | 16.1/25 ROCE 15.1% · OPM 6.4% 95% evidence | 9.6/20 P/E 51.8× · PEG — 50% evidence | 12.2/20 RS sector — · RS bench 60.1% · 1Y —2 of 2 weeks ahead 25% evidence |
| Exact sum: 15.9 + 16.1 + 9.6 + 12.2 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Arisinfra Solutions LtdARIS | 53.5/100Thin evidence · provisional53% evidence | ASLEEP | 18.1/35 Revenue 39.1% · PAT 100% · OPM change 4.5 pp 62% evidence | 15.3/25 ROCE 15.6% · OPM 9% 95% evidence | 10.9/20 P/E 19.3× · PEG — 15% evidence | 9.2/20 RS sector — · RS bench -2.4% · 1Y -11.4%4 of 10 weeks ahead 25% evidence |
| Exact sum: 18.1 + 15.3 + 10.9 + 9.2 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Aayush Art and Bullion Ltd540718 | 53.4/100Thin evidence · provisional54% evidence | TURNING | 20.9/35 Revenue 100% · PAT — · OPM change 1.6 pp 35% evidence | 13.8/25 ROCE 18.9% · OPM 6% 76% evidence | 9.0/20 P/E 233× · PEG — 15% evidence | 9.7/20 RS sector -7.3% · RS bench 8.5% · 1Y 31.9%3 of 12 weeks ahead 100% evidence |
| Exact sum: 20.9 + 13.8 + 9 + 9.7 = 53.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Onix Solar Energy Ltd513119 | 52.1/100Mixed-positive evidence75% evidence | ASLEEP | 22.1/35 Revenue 100% · PAT 100% · OPM change 23 pp 95% evidence | 11.3/25 ROCE 10% · OPM 30% 76% evidence | 10.2/20 P/E 32.4× · PEG — 15% evidence | 8.5/20 RS sector -8.1% · RS bench 29.6% · 1Y 32.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 11.3 + 10.2 + 8.5 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Bizotic Commercial Ltd543926 | 51.2/100Thin evidence · provisional58% evidence | ASLEEP | 19.7/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 19.1/25 ROCE 26.8% · OPM 8% 76% evidence | 10.4/20 P/E 29.6× · PEG — 50% evidence | 2.0/20 RS sector -38% · RS bench -27.8% · 1Y 109.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 19.1 + 10.4 + 2 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Patel Retail LtdPATELRMART | 51.2/100Thin evidence · provisional56% evidence | TURNING | 15.7/35 Revenue 27.7% · PAT 54.4% · OPM change -1.9 pp 83% evidence | 14.6/25 ROCE 15.3% · OPM 5.2% 95% evidence | 10.9/20 P/E 19.3× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —7 of 10 weeks ahead 0% evidence |
| Exact sum: 15.7 + 14.6 + 10.9 + 10 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Fabtech Technologies LtdFABTECH | 51.2/100Thin evidence · provisional52% evidence | ASLEEP | 17.4/35 Revenue 14.2% · PAT 41% · OPM change 14.8 pp 71% evidence | 12.7/25 ROCE 13.6% · OPM 5.7% 95% evidence | 11.1/20 P/E 13.7× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 17.4 + 12.7 + 11.1 + 10 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18SG Mart LtdSGMART | 50.2/100Mixed-positive evidence90% evidence | LEADER | 14.8/35 Revenue 10.4% · PAT 14.7% · OPM change 1.4 pp 95% evidence | 9.2/25 ROCE 10.2% · OPM 4.5% 95% evidence | 8.4/20 P/E 70.7× · PEG 1.92 65% evidence | 17.8/20 RS sector 32.1% · RS bench 51.9% · 1Y 94.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 9.2 + 8.4 + 17.8 = 50.2 · Decision use: Price leads the evidence: RS versus the benchmark is 51.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 19Adani Enterprises LtdADANIENT | 47.8/100Mixed-negative evidence93% evidence | LEADER | 14.6/35 Revenue 18.1% · PAT 4.2% · OPM change 0 pp 100% evidence | 8.7/25 ROCE 5.8% · OPM 15% 100% evidence | 7.7/20 P/E 172× · PEG 1.96 65% evidence | 16.8/20 RS sector 5.5% · RS bench 23.2% · 1Y 21.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.6 + 8.7 + 7.7 + 16.8 = 47.8 · Decision use: Price leads the evidence: RS versus the benchmark is 23.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 20Shiv Aum Steels LtdSHIVAUM | 47.8/100Thin evidence · provisional50% evidence | 16.7/35 Revenue — · PAT — · OPM change 0.5 pp 32% evidence | 11.5/25 ROCE 8% · OPM 3.8% 95% evidence | 7.8/20 P/E 83.3× · PEG — 50% evidence | 11.8/20 RS sector — · RS bench 35.4% · 1Y — 25% evidence | |
| Exact sum: 16.7 + 11.5 + 7.8 + 11.8 = 47.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21BN Agrochem LtdBNAGROCHEM | 47.1/100Mixed-negative evidence73% evidence | TURNING | 24.2/35 Revenue 100% · PAT 57.3% · OPM change 20.5 pp 88% evidence | 7.0/25 ROCE 4.4% · OPM 1.6% 100% evidence | 9.4/20 P/E 79.4× · PEG — 15% evidence | 6.5/20 RS sector -19.2% · RS bench -10.6% · 1Y 3.2%8 of 8 weeks ahead 70% evidence |
| Exact sum: 24.2 + 7 + 9.4 + 6.5 = 47.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.2% and the one-year return is 3.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 22Hardwyn India LtdHARDWYN | 46.2/100Mixed-negative evidence83% evidence | ASLEEP | 20.5/35 Revenue 8.3% · PAT 17.5% · OPM change 3.5 pp 83% evidence | 12.3/25 ROCE 4.8% · OPM 10% 95% evidence | 11.8/20 P/E 58.3× · PEG — 50% evidence | 1.6/20 RS sector -45.2% · RS bench -15.3% · 1Y -21.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 12.3 + 11.8 + 1.6 = 46.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23MMTC LtdMMTC | 45.3/100Mixed-negative evidence86% evidence | ASLEEP | 15.1/35 Revenue 0% · PAT 100% · OPM change -5633.5 pp 88% evidence | 9.7/25 ROCE 8.7% · OPM — 84% evidence | 13.8/20 P/E 94× · PEG 0.92 100% evidence | 6.7/20 RS sector -22.9% · RS bench -3.3% · 1Y -6.7%7 of 11 weeks ahead 70% evidence |
| Exact sum: 15.1 + 9.7 + 13.8 + 6.7 = 45.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 24State Trading Corporation of India Ltdthis pageSTCINDIA | 44.8/100Thin evidence · provisional54% evidence | TURNING | 18.6/35 Revenue — · PAT 100% · OPM change -14.6 pp 43% evidence | 7.5/25 ROCE -0.9% · OPM — 60% evidence | 12.1/20 P/E 16.2× · PEG — 50% evidence | 6.6/20 RS sector -30.7% · RS bench -1.9% · 1Y -6.2%5 of 11 weeks ahead 70% evidence |
| Exact sum: 18.6 + 7.5 + 12.1 + 6.6 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25PTC India LtdPTC | 43.3/100Mixed-negative evidence78% evidence | ASLEEP | 13.2/35 Revenue 4.6% · PAT -26.5% · OPM change -1.3 pp 83% evidence | 13.1/25 ROCE 13.4% · OPM 3.7% 76% evidence | 10.6/20 P/E 8.5× · PEG — 50% evidence | 6.4/20 RS sector -15.3% · RS bench -0.3% · 1Y -8.2%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 13.1 + 10.6 + 6.4 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26RRP Semiconductor LtdRRP | 42.7/100Thin evidence · provisional51% evidence | 12.2/35 Revenue -80% · PAT -80% · OPM change 3.3 pp 62% evidence | 5.5/25 ROCE -32.7% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.0/20 RS sector 61.8% · RS bench 6.5% · 1Y 195.8%0 of 1 week ahead 70% evidence | |
| Exact sum: 12.2 + 5.5 + 10 + 15 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Riddhi Siddhi Gluco Biols Ltd524480 | 42.3/100Mixed-negative evidence78% evidence | LEADER | 12.1/35 Revenue 74.8% · PAT 0% · OPM change -77 pp 83% evidence | 6.4/25 ROCE 2.7% · OPM -89% 76% evidence | 7.0/20 P/E 26.4× · PEG — 50% evidence | 16.8/20 RS sector 8.9% · RS bench 26.8% · 1Y 23.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 6.4 + 7 + 16.8 = 42.3 · Decision use: Price leads the evidence: RS versus the benchmark is 26.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 28Neueon Corporation LtdNEUEON | 41.8/100Thin evidence · provisional56% evidence | ASLEEP | 12.4/35 Revenue 100% · PAT -80% · OPM change -3110 pp 62% evidence | 3.5/25 ROCE -40.4% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.9/20 RS sector 16.9% · RS bench 39.6% · 1Y —7 of 12 weeks ahead 70% evidence |
| Exact sum: 12.4 + 3.5 + 10 + 15.9 = 41.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Cropster Agro Ltd523105 | 41.0/100Mixed-negative evidence65% evidence | 16.1/35 Revenue 28.4% · PAT 6.5% · OPM change 2.1 pp 83% evidence | 11.8/25 ROCE 12.4% · OPM 8.7% 76% evidence | 10.1/20 P/E 32.7× · PEG — 15% evidence | 3.0/20 RS sector -73.5% · RS bench -60.9% · 1Y -70.2%0 of 4 weeks ahead 70% evidence | |
| Exact sum: 16.1 + 11.8 + 10.1 + 3 = 41 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30Hexa Tradex LtdHEXATRADEX | 37.9/100Mixed-negative evidence65% evidence | ASLEEP | 16.8/35 Revenue 0.4% · PAT 65% · OPM change 13.6 pp 62% evidence | 4.2/25 ROCE -0.1% · OPM -191.7% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.9/20 RS sector -21.2% · RS bench -6.7% · 1Y -14.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 4.2 + 10 + 6.9 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Kothari Industrial Corporation LtdKOTIC | 35.1/100Thin evidence · provisional59% evidence | ASLEEP | 19.8/35 Revenue 100% · PAT -80% · OPM change -1 pp 62% evidence | 1.8/25 ROCE -28.9% · OPM -54% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -60% · RS bench -45.5% · 1Y -60.3%0 of 7 weeks ahead 70% evidence |
| Exact sum: 19.8 + 1.8 + 10 + 3.5 = 35.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Shanti Overseas (India) LtdSHANTI | 32.4/100Thin evidence · provisional56% evidence | 11.3/35 Revenue -63.4% · PAT 100% · OPM change -200.5 pp 40% evidence | 4.5/25 ROCE -25.2% · OPM -216.5% 71% evidence | 13.3/20 P/E 3× · PEG — 50% evidence | 3.3/20 RS sector -61.6% · RS bench -49.7% · 1Y -60.6%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 11.3 + 4.5 + 13.3 + 3.3 = 32.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Dhunseri Ventures LtdDVL | 30.8/100Adverse evidence69% evidence | ASLEEP | 11.8/35 Revenue -30.8% · PAT -38.9% · OPM change -4 pp 62% evidence | 6.0/25 ROCE 6.7% · OPM -85% 95% evidence | 8.5/20 P/E 5.4× · PEG — 50% evidence | 4.5/20 RS sector -45.9% · RS bench -14.2% · 1Y -33.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 11.8 + 6 + 8.5 + 4.5 = 30.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 34Uniphos Enterprises LtdUNIENTER | 29.0/100Adverse evidence69% evidence | ASLEEP | 13.1/35 Revenue -71.3% · PAT 100% · OPM change -0.9 pp 62% evidence | 3.0/25 ROCE 0.8% · OPM -3.1% 95% evidence | 8.3/20 P/E 31.9× · PEG — 50% evidence | 4.6/20 RS sector -45.2% · RS bench -25.4% · 1Y -41.1%1 of 10 weeks ahead 70% evidence |
| Exact sum: 13.1 + 3 + 8.3 + 4.6 = 29 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 35Oswal Agro Mills LtdOSWALAGRO | 25.9/100Adverse evidence63% evidence | ASLEEP | 4.6/35 Revenue -80% · PAT -80% · OPM change -21782 pp 83% evidence | 7.5/25 ROCE 2% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.8/20 RS sector -51.8% · RS bench -33.3% · 1Y -54.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 4.6 + 7.5 + 10 + 3.8 = 25.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 36Mardia Samyoung Capillary Tubes Company LtdMSCTC | 57.2/100Thin evidence · provisional32% evidence | 20.5/35 Revenue 100% · PAT 100% · OPM change — 29% evidence | 15.7/25 ROCE 22.6% · OPM 15.3% 57% evidence | 8.7/20 P/E 687× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 74.6% · 1Y 236.1%6 of 12 weeks ahead to 2026-03-08 25% evidence | |
| Exact sum: 20.5 + 15.7 + 8.7 + 12.3 = 57.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 37Proventus Agrocom LtdPROV | 56.9/100Thin evidence · provisional48% evidence | BREAKING OUT | 19.5/35 Revenue — · PAT — · OPM change 0.2 pp 26% evidence | 13.0/25 ROCE 11.5% · OPM 1.8% 95% evidence | 13.1/20 P/E 39.6× · PEG — 50% evidence | 11.3/20 RS sector — · RS bench 25.4% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 19.5 + 13 + 13.1 + 11.3 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 38SK Minerals & Additives Ltd544584 | 55.9/100Thin evidence · provisional31% evidence | 16.2/35 Revenue — · PAT — · OPM change 0 pp 26% evidence | 19.4/25 ROCE 26.2% · OPM 10% 76% evidence | 10.3/20 P/E 30.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 16.2 + 19.4 + 10.3 + 10 = 55.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 39Monika Alcobev LtdMONIKA | 54.6/100Thin evidence · provisional22% evidence | 16.3/35 Revenue — · PAT — · OPM change -2 pp 15% evidence | 17.6/25 ROCE 21% · OPM 15% 57% evidence | 10.7/20 P/E 20.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -9%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 16.3 + 17.6 + 10.7 + 10 = 54.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 40Pramara Promotions LtdPRAMARA | 53.1/100Thin evidence · provisional47% evidence | 16.6/35 Revenue — · PAT — · OPM change -1 pp 15% evidence | 14.3/25 ROCE 15.2% · OPM 15% 71% evidence | 7.3/20 P/E 51.3× · PEG — 50% evidence | 14.9/20 RS sector 7.6% · RS bench 29% · 1Y 72.6%10 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 16.6 + 14.3 + 7.3 + 14.9 = 53.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 41BMW Ventures LtdBMW | 52.4/100Thin evidence · provisional26% evidence | 17.9/35 Revenue — · PAT — · OPM change 0 pp 24% evidence | 13.3/25 ROCE 13.6% · OPM 4% 57% evidence | 11.2/20 P/E 13.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 17.9 + 13.3 + 11.2 + 10 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 42Manbro Industries Ltd512595 | 52.0/100Thin evidence · provisional22% evidence | 18.3/35 Revenue — · PAT — · OPM change 32.8 pp 5% evidence | 13.4/25 ROCE — · OPM 6.6% 23% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.3/20 RS sector -18.9% · RS bench 37.2% · 1Y 40.1%12 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 18.3 + 13.4 + 10 + 10.3 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 43Shah Foods Ltd519031 | 50.9/100Thin evidence · provisional17% evidence | 17.3/35 Revenue — · PAT — · OPM change -10.7 pp 3% evidence | 12.3/25 ROCE — · OPM -3.3% 30% evidence | 8.9/20 P/E 293× · PEG — 15% evidence | 12.4/20 RS sector — · RS bench 143.1% · 1Y — 25% evidence | |
| Exact sum: 17.3 + 12.3 + 8.9 + 12.4 = 50.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 44Le Merite Exports LtdLEMERITE | 48.2/100Thin evidence · provisional46% evidence | 18.9/35 Revenue — · PAT — · OPM change 0.9 pp 15% evidence | 9.3/25 ROCE 8.6% · OPM 2.8% 71% evidence | 9.3/20 P/E 87× · PEG — 15% evidence | 10.7/20 RS sector -10.6% · RS bench 15% · 1Y 42.1%1 of 1 week ahead to 2026-05-17 100% evidence | |
| Exact sum: 18.9 + 9.3 + 9.3 + 10.7 = 48.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 45Keto Motors Ltd537392 | 46.8/100Thin evidence · provisional21% evidence | 17.0/35 Revenue — · PAT -41.7% · OPM change — 12% evidence | 7.3/25 ROCE -2.2% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 378.2% · 1Y — 25% evidence | |
| Exact sum: 17 + 7.3 + 10 + 12.5 = 46.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 46Satani Bearings Ltd505703 | 45.0/100Thin evidence · provisional37% evidence | ASLEEP | 20.1/35 Revenue — · PAT 100% · OPM change — 29% evidence | 4.9/25 ROCE 1% · OPM 1.5% 76% evidence | 8.5/20 P/E 11020× · PEG — 15% evidence | 11.5/20 RS sector — · RS bench 28.3% · 1Y 153.4%0 of 10 weeks ahead 25% evidence |
| Exact sum: 20.1 + 4.9 + 8.5 + 11.5 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 47A-1 LtdA1L | 41.5/100Thin evidence · provisional50% evidence | 16.1/35 Revenue 8.3% · PAT -30.6% · OPM change -0.9 pp 53% evidence | 11.1/25 ROCE 10.6% · OPM 2.9% 57% evidence | 8.8/20 P/E 383× · PEG — 15% evidence | 5.5/20 RS sector -26.6% · RS bench -16% · 1Y 26.3%6 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 16.1 + 11.1 + 8.8 + 5.5 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 48Blue Pearl Agriventures LtdBPAGRI | 38.5/100Thin evidence · provisional50% evidence | 17.1/35 Revenue 100% · PAT -46.7% · OPM change -2.5 pp 53% evidence | 7.8/25 ROCE 2.6% · OPM 2.8% 57% evidence | 8.6/20 P/E 5705× · PEG — 15% evidence | 5.0/20 RS sector -35.6% · RS bench -25.1% · 1Y -37.5%1 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 17.1 + 7.8 + 8.6 + 5 = 38.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is State Trading Corporation of India Ltd's share price today?
State Trading Corporation of India Ltd trades at ₹121, −3.2% over the past year. The company is valued at ₹723 Cr. The stock sits at 46% of its 52-week range of ₹99–₹145, −1.2% versus its 200-day average. On the tape, the price is building a base, 7 weeks in. — as of 31 July 2026.
What were State Trading Corporation of India Ltd's latest quarterly results?
State Trading Corporation of India Ltd reported revenue of ₹0.0 Cr and net profit of ₹17.0 Cr for the Dec 25 quarter. Earnings per share were ₹2.76. — as of 31 July 2026.
What is State Trading Corporation of India Ltd's revenue?
State Trading Corporation of India Ltd reported revenue of ₹0.0 Cr in the Dec 25 quarter. For the full FY25 fiscal year, revenue was ₹0.0 Cr. — as of 31 July 2026.
What is State Trading Corporation of India Ltd's profit?
State Trading Corporation of India Ltd earned ₹17.0 Cr of net profit in the Dec 25 quarter, +750.0% year on year. Full-year FY25 profit was ₹25.0 Cr. — as of 31 July 2026.
What is State Trading Corporation of India Ltd's market cap?
State Trading Corporation of India Ltd's market capitalisation is ₹723 Cr at a share price of ₹121. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is State Trading Corporation of India Ltd's P/E ratio?
State Trading Corporation of India Ltd trades at a P/E of 16.2×, at the 50th percentile of its own 5-year range, against a long-run median of 16.4×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does State Trading Corporation of India Ltd pay a dividend?
No — State Trading Corporation of India Ltd has recorded a dividend payout of 0% of profit in each of its last 12 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 31 July 2026.
Is State Trading Corporation of India Ltd overvalued?
On its own history, State Trading Corporation of India Ltd looks mid-range against its own history: its P/E of 16.2× sits at the 50th percentile of its 5-year range (long-run median 16.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 31 July 2026.
How is State Trading Corporation of India Ltd performing?
State Trading Corporation of India Ltd is building a base, 7 weeks in. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is State Trading Corporation of India Ltd in an uptrend?
No — the price is building a base (week 7 of stage 1), trading −1.2% versus its 200-day average and at 46% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is State Trading Corporation of India Ltd beating the market?
Not lately — on a trailing-13-week view State Trading Corporation of India Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +39% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.
Will State Trading Corporation of India Ltd's share price go up?
This page publishes no price forecast for State Trading Corporation of India Ltd. What it measures instead: the share price is ₹121, the price is building a base 7 weeks in. Its P/E of 16.2× sits at the 50th percentile of its own 5-year range. — as of 31 July 2026.
Who owns State Trading Corporation of India Ltd?
Promoters hold 90.0% of State Trading Corporation of India Ltd, foreign institutions 0.0%, domestic institutions 0.5% and the public 9.5% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 31 July 2026.
Does State Trading Corporation of India Ltd have too much debt?
No — State Trading Corporation of India Ltd's debt-to-equity is −0.43, and operating profit covers the interest bill −24×. FY25 borrowings were ₹1,981 Cr against equity of ₹−4,603 Cr. The returns on this page are earned, not borrowed — as of 31 July 2026.
What is State Trading Corporation of India Ltd's capex?
State Trading Corporation of India Ltd spent ₹0.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹0.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is State Trading Corporation of India Ltd's cash flow?
State Trading Corporation of India Ltd generated ₹−171 Cr of operating cash flow in FY25 and ₹−171 Cr of free cash flow after ₹0.0 Cr of capital spending. Reported profit that year was ₹25.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is State Trading Corporation of India Ltd's profit real cash?
Not fully — over the last 3 fiscal years, −238% of State Trading Corporation of India Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹−171 Cr against reported profit of ₹25.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is State Trading Corporation of India Ltd in its business cycle?
State Trading Corporation of India Ltd's FY23 operating margin was 4,800.0%, against a 9-year band of −37.0%–4,800.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the State Trading Corporation of India Ltd story?
The sharpest disagreement: the price moved −3.2% in a year while annual EPS moved −51.6% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is State Trading Corporation of India Ltd a stock worth studying right now?
This is not investment advice. The machine read: State Trading Corporation of India Ltd's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.